Belluscura plc logo

Belluscura plc (BELL)

Market Closed
1 Jul, 15:30
LSE LSE
0. 01
GBX
0
0%
GBX
21.05M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
0.01 GBX
Previous Close
Day Range
0.01 0.01
Year Range
0.01 11
Want to track BELL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BELL closed Tuesday higher at 0.01 GBX, an increase of 0% from Monday's close, completing a monthly increase of 0% or 0 GBX. Over the past 12 months, BELL stock lost -99.92%.
BELL is not paying dividends to its shareholders.
The last earnings report, released on Sep 24, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

BELL Chart

Similar

FAB
Fusion Antibodies Ltd.
- GBX
-
Crism Therapeutics Corporation
10 GBX
+14.29%

Belluscura plc (BELL) FAQ

What is the stock price today?

The current price is 0.01 GBX.

On which exchange is it traded?

Belluscura plc is listed on XFRA.

What is its stock symbol?

The ticker symbol is BELL.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 21.05M.

Has Belluscura plc ever had a stock split?

No, there has never been a stock split.

Belluscura plc Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Robert Rauker CEO
LSE Exchange
GB00BD3B8Z11 ISIN
United Kingdom Country
35 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Belluscura plc is a pioneering company specializing in the development and commercialization of oxygen-related medical device products primarily targeting users in the United States. Since its establishment in 2015, with its headquarters set in London, the United Kingdom, Belluscura has been at the forefront of innovation in the field of portable oxygen concentrators. The company's mission is geared towards improving the quality of life for people requiring oxygen therapy by offering advanced, lightweight, and modular solutions that ensure users lead an active life with fewer constraints.

Products and Services

  • X-PLOR
  • The X-PLOR portable oxygen concentrator stands out as a signature product of Belluscura plc. Designed with versatility and user mobility in mind, this device aims to provide users with a reliable source of oxygen while on the move. Its modular nature allows for easy customization to accommodate the varying needs of oxygen therapy patients, promoting enhanced freedom and an active lifestyle.

  • DISCOV-R
  • As another innovative solution, the DISCOV-R portable oxygen concentrator complements Belluscura's product lineup by offering a more advanced, yet still highly transportable, option for oxygen therapy. Catering to a broad range of oxygen needs, this device integrates cutting-edge technology to ensure efficient and effective oxygen delivery, supporting improved patient outcomes.

  • Related Accessories
  • Belluscura extends its product range by offering a variety of accessories compatible with both the X-PLOR and DISCOV-R oxygen concentrators. These accessories are designed to enhance the user experience, ensuring that the devices meet the specific needs and preferences of each individual. From carrying bags that facilitate ease of movement to batteries that extend the usage time on the go, Belluscura ensures that its customers have everything they need for uninterrupted oxygen therapy.

Contact Information

Address: 15 Fetter Lane
Phone: 888-626-5598